Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Current Leases (2023 - 2025)

Historic Current Leases for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $159000.0.

  • Tonix Pharmaceuticals Holding's Current Leases fell 4218.18% to $159000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $159000.0, marking a year-over-year decrease of 4218.18%. This contributed to the annual value of $274000.0 for FY2024, which is 148.15% up from last year.
  • Per Tonix Pharmaceuticals Holding's latest filing, its Current Leases stood at $159000.0 for Q3 2025, which was down 4218.18% from $195000.0 recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Current Leases registered a high of $438000.0 during Q1 2023, and its lowest value of $159000.0 during Q3 2025.
  • In the last 3 years, Tonix Pharmaceuticals Holding's Current Leases had a median value of $275000.0 in 2024 and averaged $297272.7.
  • Its Current Leases has fluctuated over the past 5 years, first soared by 148.15% in 2024, then tumbled by 4218.18% in 2025.
  • Tonix Pharmaceuticals Holding's Current Leases (Quarter) stood at $270000.0 in 2023, then rose by 1.48% to $274000.0 in 2024, then plummeted by 41.97% to $159000.0 in 2025.
  • Its Current Leases stands at $159000.0 for Q3 2025, versus $195000.0 for Q2 2025 and $235000.0 for Q1 2025.